Active — Not RecruitingPhase 1/2

CMTS0515-auWMT for Radiation Enteritis

China60 participantsStarted 2025-12-08

Plain-language summary

This is a randomized controlled trial to explore the exploring the non-inferiority of CMTS0515-augmented WMT compared to WMT.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Absence of intestinal symptoms or transient intestinal symptoms;
✕. Radiation treatment involving areas outside the abdomen and pelvis;
✕. Diagnosis of antibiotic-associated diarrhea or use of antibiotics within four weeks before enrollment;
✕. Presence of intestinal comorbidities, including inflammatory bowel disease or pseudomembranous colitis;
✕. Presence of severe conditions rendering the patient unsuitable for inclusion;
✕. Experience of bowel surgery for RE-associated fistula.

The clinical response rate after treatment

Timeframe: 1 week, 4 weeks and 8 weeks

NCT IDNCT07331688

SponsorThe Second Hospital of Nanjing Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-11-30